Quick Answer
Kiniksa Pharmaceuticals International, plc reported Total Assets of $763.63 million for fiscal year 2025.
Kiniksa Pharmaceuticals International, plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $763.63M | +31.5% |
| 2024 | $580.55M | +10.3% |
| 2023 | $526.32M | +14.5% |
| 2022 | $459.67M | +97.5% |
| 2021 | $232.80M | -33.4% |
| 2020 | $349.46M | +37.3% |
| 2019 | $254.53M | -20.9% |
| 2018 | $321.96M | +577.9% |
| 2017 | $47.49M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $712.33M | +28.3% | +7.7% |
| June 30, 2025 | $661.15M | +21.9% | +10.3% |
| March 31, 2025 | $599.33M | +15.3% | +3.2% |
| December 31, 2024 | $580.55M | +10.3% | +4.5% |
| September 30, 2024 | $555.30M | +15.0% | +2.4% |
| June 30, 2024 | $542.43M | +12.0% | +4.4% |
| March 31, 2024 | $519.67M | +17.3% | -1.3% |
| December 31, 2023 | $526.32M | +14.5% | +9.0% |
- Kiniksa Pharmaceuticals International, plc showed an increase of +31.5% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Kiniksa Pharmaceuticals International, plc’s total assets has grown by 1507.9% (from $47.49 million to $763.63 million).
- The most recent figure is from Kiniksa Pharmaceuticals International, plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: